MultiOMICs landscape of SARS-CoV-2
Jan 3, 2023MultiOMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells.
iScience (2022) https://doi.org/10.1016/j.isci.2022.105895
COVID-19 pandemic continues to remain a global health concern due to the
emergence of newer variants. Several multiOmics studies have produced
extensive evidence on host-pathogen interactions and potential
therapeutic targets. Nonetheless, an increased understanding of host
signaling networks regulated by post-translational modifications and
their ensuing effect on the cellular dynamics is critical to expanding
the current knowledge on SARS-CoV-2 infections. Through an unbiased
transcriptomics, proteomics, acetylomics, phosphoproteomics, and
exometabolome analysis of a lung-derived human cell line, we show that
SARS-CoV-2 Norway/Trondheim-S15 strain induces time-dependent
alterations in the induction of type I IFN response, activation of DNA
damage response, dysregulated Hippo signaling, among others. We
identified interplay of phosphorylation and acetylation dynamics on host
proteins and its effect on the altered release of metabolites,
especially organic acids and ketone bodies. Together, our findings serve
as a resource of potential targets that can aid in designing novel
host-directed therapeutic strategies.
Maria Górna contributed the analysis of structural models of SARS-CoV-2 proteins - mapped the identified phosphorylation sites and interpreted their possible role in the viral infection and immune defense.